Header Logo

Connection

MUSTAFA OZEN to MicroRNAs

Back to Details
This is a "connection" page, showing publications MUSTAFA OZEN has written about MicroRNAs.
MUSTAFA OZEN
Connection Strength
3.018
MicroRNAs
  1. MicroRNAs as prognostic markers in prostate cancer. Prostate. 2019 02; 79(3):265-271.
    View in: PubMed
    Score: 0.250
  2. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens. BMC Cancer. 2016 11 05; 16(1):853.
    View in: PubMed
    Score: 0.218
  3. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. Cell Oncol (Dordr). 2016 Apr; 39(2):187-93.
    View in: PubMed
    Score: 0.205
  4. The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells. Tumour Biol. 2016 Mar; 37(3):4183-92.
    View in: PubMed
    Score: 0.203
  5. Role of miR-145 in human laryngeal squamous cell carcinoma. Head Neck. 2016 Feb; 38(2):260-6.
    View in: PubMed
    Score: 0.198
  6. Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression. Cancer Invest. 2015 Jul; 33(6):251-8.
    View in: PubMed
    Score: 0.197
  7. MiR-221 as a pre- and postoperative plasma biomarker for larynx cancer patients. Laryngoscope. 2015 Dec; 125(12):E377-81.
    View in: PubMed
    Score: 0.197
  8. Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension. Medicine (Baltimore). 2015 Apr; 94(13):e693.
    View in: PubMed
    Score: 0.195
  9. Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells. J Gene Med. 2014 Nov-Dec; 16(11-12):331-5.
    View in: PubMed
    Score: 0.190
  10. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer. Int J Cancer. 2015 Feb 15; 136(4):875-9.
    View in: PubMed
    Score: 0.186
  11. miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer. PLoS One. 2014; 9(6):e98675.
    View in: PubMed
    Score: 0.185
  12. The role of miRNAs in cancer: from pathogenesis to therapeutic implications. Future Oncol. 2014 May; 10(6):1027-48.
    View in: PubMed
    Score: 0.183
  13. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. J Neurooncol. 2013 Nov; 115(2):143-51.
    View in: PubMed
    Score: 0.174
  14. MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients. Mol Biol Rep. 2013 Jul; 40(7):4619-23.
    View in: PubMed
    Score: 0.171
  15. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene. 2008 Mar 13; 27(12):1788-93.
    View in: PubMed
    Score: 0.116
  16. Comparison of microRNA expression levels in patients with schizophrenia before and after electroconvulsive therapy. Psychiatr Genet. 2024 Aug 01; 34(4):79-85.
    View in: PubMed
    Score: 0.092
  17. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy. PLoS One. 2017; 12(6):e0179543.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.